论文部分内容阅读
通过95例再障治疗总结,目前随着对再障发病机制的进一步了解,治疗方案的不断改进其有效率不断增加。雄性素的应用使慢性再障有效率达64.3%,同时加用胚胎肝治疗其疗效达75%。近年来免疫抑制剂(抗胸腺球蛋白)的应用。使急性型再障的疗效从大部分死亡到66.6%。
Through the summary of 95 cases of aplastic anemia, at present with the further understanding of the pathogenesis of aplastic anemia, the continuous improvement of the treatment plan, its efficiency is increasing. The application of androgens make the effective rate of chronic aplastic anemia up to 64.3%, while the addition of embryo liver treatment of its efficacy up to 75%. In recent years, immunosuppressive agents (anti-thymoglobulin) application. The efficacy of acute type of aplastic anemia from most of death to 66.6%.